To see the other types of publications on this topic, follow the link: 4-thiazolidinedione.

Journal articles on the topic '4-thiazolidinedione'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic '4-thiazolidinedione.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Chawla, P., Garg P, Panjwani D, and S. A. Saraf. "Synthesis of Some Novel 5-Substituted Arylidene – 2, 4 –Thiazolidinediones as Bioactive Agents." International Journal of Pharmaceutical Sciences and Nanotechnology 4, no. 1 (2011): 1373–78. http://dx.doi.org/10.37285/ijpsn.2011.4.1.10.

Full text
Abstract:
A series of 5-substituted arylidine-2, 4-thiazolidinediones derivatives were synthesized from 2, 4-thiazolidinedione and substituted aromatic aldehydes. The synthesized title compounds were screened for their in-vivo anti-inflammatory and analgesic and in-vitro antioxidant activities as per standard protocols. All the compounds were found to possess significant activities
APA, Harvard, Vancouver, ISO, and other styles
2

Kaválek, Jaromír, Vladimír Macháček, and Vojeslav Štěrba. "Coupling Kinetics of 4-Sulfobenzenediazonium Ion with 2,4-Thiazolidinedione, Its 3-Methyl Derivative and 3-Methyl-5-isoxazolone." Collection of Czechoslovak Chemical Communications 59, no. 9 (1994): 2022–28. http://dx.doi.org/10.1135/cccc19942022.

Full text
Abstract:
3- and 4-substituted 5-phenylazo derivatives of 2,4-thiazolidinedione were prepared as potential biologically active fungicides. The kinetics of coupling of 4-sulfobenzenediazonium salt with 2,4-thiazolidinedione and 3-methyl-2,4-thiazolidinedione have been studied and the results have been compared with kinetic data of coupling reaction of 3-methyl-5-isoxazolone.
APA, Harvard, Vancouver, ISO, and other styles
3

Klopper, Joshua P., William R. Hays, Vibha Sharma, Margaret A. Baumbusch, Jerome M. Hershman та Bryan R. Haugen. "Retinoid X receptor-γ and peroxisome proliferator-activated receptor-γ expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment". Molecular Cancer Therapeutics 3, № 8 (2004): 1011–20. http://dx.doi.org/10.1158/1535-7163.1011.3.8.

Full text
Abstract:
Abstract Poorly differentiated, metastatic thyroid cancer is difficult to treat. These tumors often do not concentrate radioactive iodine and may require chemotherapy, which is suboptimal and toxic. Nuclear hormone receptors peroxisome proliferator-activated receptor γ (PPARγ) and retinoid X receptor (RXR) are variably expressed in thyroid carcinoma cell lines. Expression of these receptors may predict thyroid cancer cell response to treatment with rexinoids and thiazolidinediones. We studied three thyroid carcinoma cell lines: BHP 5-16 (PPARγ−/RXRγ+), BHP 2-7 (PPARγ±/RXRγ−), and DRO-90 (RXRγ+
APA, Harvard, Vancouver, ISO, and other styles
4

Maji, Deepanwita, Subir Samanta, and Vaishali M. Patil. "In Silico ADMET and Docking Studies of Thiazolidinedione-acetic-acid Hybrids as Antidiabetics with Cardioprotection." Letters in Drug Design & Discovery 17, no. 12 (2020): 1475–84. http://dx.doi.org/10.2174/1570180817999200618103328.

Full text
Abstract:
Background: Type-2-diabetes mellitus is associated with many side effects affecting vital body organs, especially heart. Thiazolidinediones are potent antidiabetics. Studies have proven that amino-acids and peptides promote glucose transport, have antioxidant properties, and fewer side effects, thus we designed hybrids by combining amino-acid esters and peptide esters with 2, 4 thiazolidinedione acetic acid moiety which can act as antidiabetic agent with cardioprotection properties. Methodology: In vitro ADME, toxicity, and docking studies were performed using Qikprop3.1.OSIRIS, PROTOX (Predic
APA, Harvard, Vancouver, ISO, and other styles
5

Wilmsen, Hubertina M., Theodore P. Ciaraldi, Leslie Carter, Nabeela Reehman, Sunder R. Mudaliar, and Robert R. Henry. "Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects." American Journal of Physiology-Endocrinology and Metabolism 285, no. 2 (2003): E354—E362. http://dx.doi.org/10.1152/ajpendo.00491.2001.

Full text
Abstract:
We examined the regulation of free fatty acid (FFA, palmitate) uptake into skeletal muscle cells of nondiabetic and type 2 diabetic subjects. Palmitate uptake included a protein-mediated component that was inhibited by phloretin. The protein-mediated component of uptake in muscle cells from type 2 diabetic subjects (78 ± 13 nmol · mg protein-1 · min-1) was reduced compared with that in nondiabetic muscle (150 ± 17, P < 0.01). Acute insulin exposure caused a modest (16 ± 5%, P < 0.025) but significant increase in protein-mediated uptake in nondiabetic muscle. There was no significant insu
APA, Harvard, Vancouver, ISO, and other styles
6

Chavan, Rajashree, Komal Chandhere та Ashok Bhosale. "Design, Synthesis, Biological Evaluation of Tnf-α Inhibi- Tors As Antidiabetic Agents". PDEAS International Journal of Research in Ayurved and Allied Sciences 1, № 1 (2019): 11–17. https://doi.org/10.63778/pdeasijraas-arjcpl/2019_21511.

Full text
Abstract:
The weight loss in obese patients is associated with reduced Tumor necrosis factor-α (TNF-α) production and ameliorated insulin resistance. TNF-α has been shown to be an important mediator of insulin resistance linked to obesity. TNF-α interferes with insulin-signaling by inhibiting tyrosine kinase activity of the insulin receptor and the serine phosphorylation of insulin receptor substrate-1 (IRS-1). Thiazolidinediones serve as a boom in the antidiabetic therapy by increasing the sensitivity of insulin receptors towards insulin. The present study aims at designing novel thiazolidinediones wit
APA, Harvard, Vancouver, ISO, and other styles
7

Pinson, Jo-Anne, Oleg Schmidt-Kittler, Mark Frazzetto, et al. "Synthesis and Pharmacological Evaluation of 4-Iminothiazolidinones for Inhibition of PI3 Kinase." Australian Journal of Chemistry 65, no. 10 (2012): 1396. http://dx.doi.org/10.1071/ch12140.

Full text
Abstract:
The thiazolidinedione, compound 1, has previously shown pan-inhibition of the phosphoinositide 3-kinase (PI3K) class I isoforms. We hypothesized the derivatization of the thiazolidinedione core of compound 1 could introduce isoform selectivity. We report the synthesis, characterization, and inhibitory activity of a novel series of 4-iminothiazolidin-2-ones for inhibition of the class I PI3K isoforms. Their synthesis was successfully achieved by multiple pathways described in this paper. Initial in vitro data of 28 analogues demonstrated poor inhibition of all class I PI3K isoforms. However, we
APA, Harvard, Vancouver, ISO, and other styles
8

Yakubu-Madus, F. E., T. W. Stephens, and W. T. Johnson. "Lipid lowering explains the insulin sensitivity enhancing effects of a thiazolidinedione, 5-(4-(2-(2-phenyl-4-oxazolyl)ethoxy)benzyl)-2,4 thiazolidinedione*." Diabetes, Obesity and Metabolism 2, no. 3 (2000): 155–63. http://dx.doi.org/10.1046/j.1463-1326.2000.00075.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bannunah, Azzah M., Naeem Fqusty, Bayan Tayeb Bokhari, Saad Alghamdi, Waheeb Alharbi, and Mohammad Asif. "Synthesis and in vitro antihyperglycemic evaluation of some new 3-(4-ethyl-6-methyl pyrimidin-2-yl)-2-arylthiazolidin-4-one derivatives." INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 35, no. 01 (2025): 85. https://doi.org/10.59467/ijhc.2025.35.85.

Full text
Abstract:
Due to the pharmacological potential of thiazolidinedione derivatives as antidiabetic drugs, six pyrimidine hybrids of aryl thiazolidin-4-ones (2a-f) were synthesized in two steps. In the first step, 4-ethyl-6-methyl-pyrimidin-2-amine (1) was synthesized by reacting 1,3-hexane-2,4-dione with guanidine. Compound 1 reacted with appropriate aryl aldehyde and mercaptoacetic acid to form compounds 2a-f. All the compounds (2a-f) exhibited varying degrees of a-amylase inhibitory activity, particularly compounds 2b (IC50 = 25 μg/mL), 2f (IC50 = 30 μg/mL), 2a and 2c (IC50 = 35 μg/mL) exhibited consider
APA, Harvard, Vancouver, ISO, and other styles
10

Zvarec, Ondrej, Steven W. Polyak, William Tieu, et al. "5-Benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials." Bioorganic & Medicinal Chemistry Letters 22, no. 8 (2012): 2720–22. http://dx.doi.org/10.1016/j.bmcl.2012.02.100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Chis, Irina C., Doina Baltaru, Simona Clichici, Ovidiu Oniga, Ileana Cojocaru, and Cristina Nastasa. "The Effects of a 5-Chromene-yl-thiazolidin-2,4-dione Derivative in Alleviating Oxidative Stress in Adjuvant-Induced Arthritis." Revista de Chimie 69, no. 9 (2018): 2361–65. http://dx.doi.org/10.37358/rc.18.9.6534.

Full text
Abstract:
Rheumatoid arthritis (RA) is a chronic inflammatory disease that reduces life quality and requires long-life therapy. Quercetin (Que) is a natural flavonoid with antioxidant and anti-inflammatory effects. (3-(2-(4-Chlorophenyl)-2-oxoethyl)-5-((6-methyl-4-oxo-4H-chromen-3-yl)methylene) thiazolidine-2,4-dione (TZD) is a thiazolidinedione derivative synthesized in our laboratory. This study was designed to investigate the antioxidant effects of the Que and TZD derivative administration in adjuvant-induced arthritic (AIA) rats. AIA was induced in Wistar rats by the intraplantar injection of Freund
APA, Harvard, Vancouver, ISO, and other styles
12

Begum, Arifa, Shaheen Begum, Prasad Kvsrg, and Bharathi K. "IN SILICO STUDIES ON FUNCTIONALIZED AZAGLYCINE DERIVATIVES CONTAINING 2, 4-THIAZOLIDINEDIONE SCAFFOLD ON MULTIPLE TARGETS." International Journal of Pharmacy and Pharmaceutical Sciences 9, no. 8 (2017): 209. http://dx.doi.org/10.22159/ijpps.2017v9i8.19835.

Full text
Abstract:
Objective: The 2, 4-thiazolidinedione containing compounds could lead to most promising scaffolds with higher efficiency toward the targets recognized for its antidiabetic activity when combined with azaglycine moiety. The objective of the present work was to merge functionalized aza glycines with 2, 4-thiazolidinediones, perform in silico evaluation by molecular properties prediction and undertake the molecular docking studies with targets relevant to diabetes, bacterial and viral infections using Swiss Dock programme for unraveling the target identification which can be used for further desi
APA, Harvard, Vancouver, ISO, and other styles
13

A., N. A. Verdizade K. A. Kuliev K. A. Alieva R. A. Ismailova. "EXTRACTION AND SPECTROPHOTOMETRIC DETERMINATION OF COBALT (II) WITH 3-PHENYL-2, 4-THIAZOLIDINEDIONE." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 11 (2018): 12382–91. https://doi.org/10.5281/zenodo.1490077.

Full text
Abstract:
<em>3-Phenyl<strong>-</strong>2,4- thiazolidinedione (PhTAD) is proposed as an analytical reagent for the extractive spectrophotometric determination of cobalt(II). PhTAD forms blue colored complex with cobalt(II) in the pH range 4.0&ndash;5.9. Beer&rsquo;s law is obeyed in the concentration range up to 16 </em><em>&mu;</em><em>g mL<sup>&minus;1</sup>. The yellowish Co(II)-PhTAD complex shows a maximum absorbance at 495 nm, with molar absorptivity of 2.62 &times; 10<sup>4 </sup>dm<sup>3</sup> mol<sup>&minus;1</sup> cm<sup>&minus;1</sup> and Sandell&rsquo;s sensitivity of the complex obtained f
APA, Harvard, Vancouver, ISO, and other styles
14

Rahman, Safikur, Md Tabish Rehman, Gulam Rabbani, et al. "Insight of the Interaction between 2,4-thiazolidinedione and Human Serum Albumin: A Spectroscopic, Thermodynamic and Molecular Docking Study." International Journal of Molecular Sciences 20, no. 11 (2019): 2727. http://dx.doi.org/10.3390/ijms20112727.

Full text
Abstract:
Thiazolidinedione derivatives (TZDs) have attracted attention because of their pharmacological effects. For example, certain TZDs have been reported to ameliorate type II diabetes by binding and activating PPARs (peroxisome proliferator-activated receptors). Nonetheless, no information is available on the interaction between the heterocyclic 2, 4-thiazolidinedione (2,4-TZD) moiety and serum albumin, which could affect the pharmacokinetics and pharmacodynamics of TZDs. In this study, we investigated the binding of 2,4-TZD to human serum albumin (HSA). Intrinsic fluorescence spectroscopy reveale
APA, Harvard, Vancouver, ISO, and other styles
15

Uwabagira, Nadine, Balladka K. Sarojini, and Ashwini Prabhu. "Synthesis, In Vitro Anticancer, Anti-Inflammatory and DNA Binding Activity of Thiazolidinedione Derivatives." Anti-Cancer Agents in Medicinal Chemistry 20, no. 14 (2020): 1704–13. http://dx.doi.org/10.2174/1871520620666200424102615.

Full text
Abstract:
Background: Cancer is the second leading cause of mortality worldwide. Despite several advances made in the treatment strategies, the cure for cancer remains still a challenge. Currently used treatment modalities pose several side effects and remain ineffective in the later stages. Thiazolidinediones (TZDs) have been shown to possess anti-cancer activity in several in vitro models. Objectives: The objective of this study was to assess the effect of novel synthesized thiazolidinedione derivatives on three selected cancer cell lines viz., human breast adenocarcinoma cell line (MCF-7), lung adeno
APA, Harvard, Vancouver, ISO, and other styles
16

Kyle, Kimberly A., Thomas L. Willett, Laurie L. Baggio, Daniel J. Drucker та Marc D. Grynpas. "Differential Effects of PPAR-γ Activation versus Chemical or Genetic Reduction of DPP-4 Activity on Bone Quality in Mice". Endocrinology 152, № 2 (2010): 457–67. http://dx.doi.org/10.1210/en.2010-1098.

Full text
Abstract:
Abstract Patients with type 2 diabetes mellitus have an increased risk of fracture that can be further exacerbated by thiazolidinediones. A new class of antidiabetic agents control glucose through reduction of dipeptidyl peptidase-4 (DPP-4) activity; however the importance of DPP-4 for the control of bone quality has not been extensively characterized. We compared the effects of the thiazolidinedione pioglitazone and the DPP-4 inhibitor sitagliptin on bone quality in high-fat diet (HFD)-fed wild-type mice. In complementary studies, we examined bone quality in Dpp4+/+ vs. Dpp4−/− mice. Pioglita
APA, Harvard, Vancouver, ISO, and other styles
17

Schwab, A. M., S. Granholm, E. Persson, B. Wilkes, U. H. Lerner, and H. H. Conaway. "Stimulation of Resorption in Cultured Mouse Calvarial Bones by Thiazolidinediones." Endocrinology 146, no. 10 (2005): 4349–61. http://dx.doi.org/10.1210/en.2005-0601.

Full text
Abstract:
Dosage-dependent release of 45Ca was observed from prelabeled mouse calvarial bones after treatment with two thiazolidinediones, troglitazone and ciglitazone. Release of 45Ca by ciglitazone was decreased by the osteoclast inhibitors acetazolamide, calcitonin, 3-amino-1-hydroxypropylidene-1,1-bisphosphonate, and IL-4, but not affected by the peroxisome proliferator-activated receptor γ antagonist, GW 9662, the mitotic inhibitor, hydroxyurea, or indomethacin. Enhanced expression of receptor activator of nuclear factor-κB ligand (RANKL) mRNA and protein and decreased osteoprotegerin (OPG) mRNA an
APA, Harvard, Vancouver, ISO, and other styles
18

Sonawane, L. V., and S. B. Bari. "Synthesis and Spectral Characterization of Some Novel N-Substituted 2, 4-Thiazolidinedione." International Journal of Biological Chemistry 5, no. 1 (2010): 68–74. http://dx.doi.org/10.3923/ijbc.2011.68.74.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Nastasă, Cristina Mariana, Mihaela Duma, Adrian Pîrnău, Laurian Vlase, Brîndușa Tiperciuc, and Ovidiu Oniga. "Development of new 5-chromenyl-2,4-thiazolidinediones as antimicrobial agents." Medicine and Pharmacy Reports 89, no. 1 (2015): 122–27. http://dx.doi.org/10.15386/cjmed-509.

Full text
Abstract:
Background and aims. In the context of the increasing phenomenon of microbial resistance to usual drugs, the development of new treatment strategies and new therapeutic protocols is a constant need. Thiazolidinedione and chromone represent two important scaffolds in medicinal chemistry due to their large pharmacological applicability.Methods. We synthesized a new 5-(chromene-3-yl)methylene-2,4-thiazolidinedione starting from 6,8-dichloro-4-oxo-4H-chromene-3-carbaldehyde. Then, by treating with different α-bromoalkylarylketones, we obtained N-substituted derivatives. All new compounds were inve
APA, Harvard, Vancouver, ISO, and other styles
20

Munwar, Shaik, K. Ilango, and M. K. Kathiravan. "Synthesis, Molecular Docking Studies and in vitro and in vivo Hypolipidemic Activity of Thiazolidinedione Derivatives." Asian Journal of Chemistry 36, no. 2 (2024): 434–48. http://dx.doi.org/10.14233/ajchem.2024.31107.

Full text
Abstract:
This work aimed to design, synthesize novel thiazolidinedione derivatives, which were tested for their antihyperlipidemic effects. Antihyperlipidemic activity was carried through in silico docking study for the 50 thiazolidinedione derivatives (SMI-IV-1 to 50 derivatives) in comparison with standard pioglitazone against the crystal structure of protein PPARgamma (PDB ID: 6QJ5) proteins. Based on the binding energy further, best three derivatives were selected and characterized with IR, NMR and MASS studies. Then, in vitro evaluation of each derivative's antihyperlipidemic activity was carried
APA, Harvard, Vancouver, ISO, and other styles
21

Ortmeyer, Heidi K., Noni L. Bodkin, Joseph Haney, Shinji Yoshioka, Hiroyoshi Horikoshi, and Barbara C. Hansen. "A Thiazolidinedione ImprovesIn VivoInsulin Action on Skeletal Muscle Glycogen Synthase in Insulin-Resistant Monkeys." International Journal of Experimental Diabetes Research 1, no. 3 (2000): 195–202. http://dx.doi.org/10.1155/edr.2000.195.

Full text
Abstract:
Thiazolidinediones (TZD) have been shown to have anti-diabetic effects including the ability to decrease fasting hyperglycemia and hyperinsulinemia, increase insulin-mediated glucose disposal rate (M) and decrease hepatic glucose production, but the mechanisms of action are not well established. To determine whether a TZD (R-102380, Sankyo Company Ltd., Tokyo, Japan) could improve insulin action on skeletal muscle glycogen synthase (GS), the rate-limiting enzyme in glycogen synthesis, 4 insulin-resistant obese monkeys were given I mg/kg/ day R-102380 p.o. for a 6-week period. Skeletal muscle G
APA, Harvard, Vancouver, ISO, and other styles
22

Anil, Saini, S. Bhatti Ravinder, and S. Sandhu Jagir. "LiBr catalyzed, microwave enhanced synthesis of 5-arylidene rhodanine under solvent free conditions." Journal of Indian Chemical Society Vol. 84, Dec 2007 (2007): 1239–41. https://doi.org/10.5281/zenodo.5825137.

Full text
Abstract:
Department of Chemistry, Punjabi University, Patiala-147 002, Punjab, India <em>E-mail </em>: j_sandhu2002@yahoo.com Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala-147 002, Punjab, India <em>Manuscript received 25 June 2007, accepted 13 September 2007</em> A variety of aldehydes&nbsp;&nbsp;are condensed with rhodaninc under solvent free conditions&nbsp;using LiBr affording 5-arylidene rhodanines in excellent yields. Also this reaction protocol in extendable to other related systems like pyrazol-5-one and 2,4-thiazolidinedione.
APA, Harvard, Vancouver, ISO, and other styles
23

Nakamura, Shinsuke, Kei Hayashi, Haruka Takizawa, et al. "An Arylidene-Thiazolidinedione Derivative, GPU-4, without PPARγ Activation, Reduces Retinal Neovascularization." Current Neurovascular Research 8, no. 1 (2011): 25–34. http://dx.doi.org/10.2174/156720211794520224.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Ha, Jeonghoon, Yejee Lim, Mee Kyoung Kim, et al. "Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus." Endocrinology and Metabolism 36, no. 4 (2021): 895–903. http://dx.doi.org/10.3803/enm.2021.1026.

Full text
Abstract:
Background: Prospective comparative studies on the effects of various antidiabetic agents on bone metabolism are limited. This study aimed to assess changes in bone mass and biochemical bone markers in postmenopausal patients with type 2 diabetes mellitus (T2DM).Methods: This prospective, multicenter, open-label, comparative trial included 264 patients with T2DM. Patients who had received a metformin, or sulfonylurea/metformin combination (Group 1); a thiazolidinedione combination (Group 2); a dipeptidyl peptidase-4 inhibitor (gemigliptin) combination (Group 3); or an sodium-glucose cotranspor
APA, Harvard, Vancouver, ISO, and other styles
25

K., A. Aliyeva. "5- (2-HYDROXYBENZYLIDENE) -2,4-TIAZOLIDINDION AS ANALYTICAL REAGENT FOR EXTRACTION-PHOTOMETRIC DETERMINATION OF COBALT (II)." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES o6, no. 08 (2019): 14980–87. https://doi.org/10.5281/zenodo.3373243.

Full text
Abstract:
<em>The possibility of using 5- (2-hydroxybenzylidene) -2,4-thiazolidinedione (L) for photo&shy;met&shy;ric determination of cobalt (II) has been studied. The best extractants were dichloroethane, chlo&shy;roform and carbon tetrachloride. With a single extraction with chloroform, 97.6% of cobalt is reco&shy;ve&shy;red as a complex. The cobalt (II) complex is extracted into chloroform in the pH range 4.0-5.3. The maximum analytical signal for the complexation of cobalt with L is observed at 530 nm. The mo&shy;lar absorption coefficient is 3.28 &times; 10<sup>4</sup>. The ratio of components in
APA, Harvard, Vancouver, ISO, and other styles
26

Scanlon, James J., and Stephen P. Wren. "Unearthing novel thiazolidinone building blocks as carboxylic acid bioisosteres." Future Medicinal Chemistry 12, no. 20 (2020): 1855–64. http://dx.doi.org/10.4155/fmc-2020-0192.

Full text
Abstract:
Aim: Thiazolidinones were prepared as building blocks for the replacement of carboxylic acids. Materials &amp; methods: Chemical syntheses of thiazolidinones were developed. In addition, the drug-likeness of the target compounds was evaluated in silico. Results: The prepared compounds included the novel structure 4; 5-(3-Iodophenylmethylene)-2,4-thiazolidinedione. Conclusion: Exploration of the methods required to synthesize thiazolidinone building blocks was completed. This work allows future generation of bioisosteric analogs of drugs.
APA, Harvard, Vancouver, ISO, and other styles
27

Schweipert, Markus, Niklas Jänsch, Neha Upadhyay, et al. "Mechanistic Insights into Binding of Ligands with Thiazolidinedione Warhead to Human Histone Deacetylase 4." Pharmaceuticals 14, no. 10 (2021): 1032. http://dx.doi.org/10.3390/ph14101032.

Full text
Abstract:
Recently, we have reported that non-hydroxamate thiazolidinedione (TZD) analogs are capable of inhibiting human deacetylase 4 (HDAC4). This study aims at the dissection of the molecular determinants and kinetics of the molecular recognition of TZD ligands by HDAC4. For this purpose, a structure activity relationship analysis of 225 analogs was combined with a comprehensive study of the enzyme and binding kinetics of a variety of HDAC4 mutant variants. The experimental data were rationalized by docking to the two major conformations of HDAC4. TZD ligands are competitive inhibitors and bind via
APA, Harvard, Vancouver, ISO, and other styles
28

H, Amin Heli, Nileshkumar Joitaram Patel, Patel Nikita, and Patel Dolar Govindbhai. "Investigation of Cardioprotective Effect of 2, 4-thiazolidinedione Derivative Using HFD-STZ Fed Rats." Indian Journal of Pharmaceutical Education and Research 57, no. 1 (2023): 173–81. http://dx.doi.org/10.5530/001954640215.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Verdizadeh, Nail A., Kerim A. Kuliev, and Konul R. Alieva. "5-(4-hydroxybenzylidene)-2,4-thiazolidinedione as analytical reagents for the extractionphotometric determination of iron(III)." Vestnik Тomskogo gosudarstvennogo universiteta. Khimiya, no. 21 (March 1, 2021): 48–59. http://dx.doi.org/10.17223/24135542/21/5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Özlem; AMİRZADEH-KHİABANİ, YILDIRIM. "Alterations of aldose reductase and superoxide dismutase activities by some chromonyl-2, 4-thiazolidinedione derivatives." Ankara Üniversitesi Veteriner Fakültesi Dergisi 61, no. 4 (2014): 249–54. http://dx.doi.org/10.1501/vetfak_0000002638.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Sunduru, Naresh, Kumkum Srivastava, S. Rajakumar, S. K. Puri, J. K. Saxena, and Prem M. S. Chauhan. "Synthesis of novel thiourea, thiazolidinedione and thioparabanic acid derivatives of 4-aminoquinoline as potent antimalarials." Bioorganic & Medicinal Chemistry Letters 19, no. 9 (2009): 2570–73. http://dx.doi.org/10.1016/j.bmcl.2009.03.026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Abbasi, Fahim, Sang-Ah Chang, James W. Chu, et al. "Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 290, no. 1 (2006): R139—R144. http://dx.doi.org/10.1152/ajpregu.00287.2005.

Full text
Abstract:
It has been suggested that changes in adiponectin levels may contribute to improved insulin sensitivity in insulin-resistant individuals both after weight loss and after treatment with thiazolidinedione compounds. If this is correct, then changes in total circulating adiponectin and/or distribution of its multimeric complexes should coincide with improvements in insulin sensitivity after both interventions. To address this issue, fasting adiponectin concentrations and distribution of adiponectin complexes were measured in plasma samples in 24 insulin-resistant, nondiabetic subjects before and
APA, Harvard, Vancouver, ISO, and other styles
33

Eremenko, Tatyana V., Nikolay A. Matsievskiy, Natalya V. Vorokhobina, Irina Y. Matesius, and Irina N. Abramashvili. "Clinical effect of thiazolidinediones in subjects with disorders of carbohydrate metabolism in case of polymorphism rs1801282." Obesity and metabolism 17, no. 2 (2020): 193–99. http://dx.doi.org/10.14341/omet9943.

Full text
Abstract:
BACKGROUND: The polymorphism rs1801282 (Pro12Ala) may be one of the reasons for the heterogeneous response of patients with carbohydrate metabolism disorders to thiazolidinedione therapy. Studies of this polymorphism in patients with metabolic syndrome (MS) will help identify a group of patients in whom the use of thiazolidinedione is advisable.&#x0D; AIMS: To assess the clinical effect of thiazolidinediones in patients with metabolic syndrome, depending on the presence of polymorphism rs1801282.&#x0D; MATERIALS AND METHODS: All patients with newly diagnosed MS with impaired carbohydrate metab
APA, Harvard, Vancouver, ISO, and other styles
34

Shukla, Karuna S., Shailendra Pandey, and Pooja Chawla. "Synthesis of Some 5-(substituted benzylidene-2, 4-dioxothiazolidin-3-yl) benzoic Acid Derivatives by Conventional and Microwave-assisted Methods and Evaluation of their Potential as Antimicrobial Agents." Anti-Infective Agents 17, no. 2 (2019): 115–29. http://dx.doi.org/10.2174/2211352516666181024151213.

Full text
Abstract:
&lt;P&gt;Background: Multiple antibiotic resistant bacteria represent a challenge in the treatment of infections. It is imperative, therefore, that new substances with antimicrobial properties should be searched to fight these microorganisms. Objective: A series of 5-benzylidene-2, 4-dioxothiazolidin-3-yl benzoic acid derivatives were synthesized and evaluated their antimicrobial potential. The compounds were synthesized by both conventional and microwave synthesizers. Methods: In this study, a series of 5-benzylidene-2, 4-dioxothiazolidin-3-yl benzoic acid derivatives were synthesized by Knoe
APA, Harvard, Vancouver, ISO, and other styles
35

Kim, Kyongyoung. "Anti-Diabetic Medications and Osteoporosis." Journal of Korean Diabetes 24, no. 4 (2023): 173–77. http://dx.doi.org/10.4093/jkd.2023.24.4.173.

Full text
Abstract:
Osteoporosis and diabetes mellitus are chronic diseases that are rapidly increasing in our aging society.Several studies have reported that the incidence of osteoporosis and fractures is increased in diabeticpatients. Although diabetes itself can affect bone density, anti-diabetic medications can also cause changesin bone mineral density, leading to osteoporosis. It is well known that thiazolidinedione increases the riskof fracture. In comparison, metformin, dipeptidyl peptidase-4 inhibitors, sodium glucose cotransporter2 inhibitors, and glucagon-like peptide-1 receptor agonists have no signif
APA, Harvard, Vancouver, ISO, and other styles
36

Barbosa, Karla P. S., Laise A. M. Santos, Edlene L. Ribeiro, et al. "Reduction of carrageenan-induced acute pulmonary inflammation in mice by novel thiazolidinedione derivative LPSF/RA-4." European Journal of Pharmacology 718, no. 1-3 (2013): 197–205. http://dx.doi.org/10.1016/j.ejphar.2013.08.033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Nadia, Aida, Antonius Herry Cahyana, Dicky Annas, Mohammad Jihad Madiabu, and Bayu Ardiansah. "Green catalyst of cobalt ferrite magnetic nanoparticles using petai peel extract for the synthesis of thiazolidinedione-based chalcone 4H-thiopyran as an antioxidant." RSC Advances 14, no. 34 (2024): 24384–97. http://dx.doi.org/10.1039/d4ra03077j.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Kim, Won Jun, Jung Hyun Noh, Kyungdo Han, and Cheol-Young Park. "The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study." Journal of Alzheimer's Disease 81, no. 3 (2021): 1263–72. http://dx.doi.org/10.3233/jad-201535.

Full text
Abstract:
Background: There are few reports that evaluated the association between various types of dementia and dual oral therapy with antihyperglycemic medication. Objective: The goal of this study was to investigate the association between treatment of dual antihyperglycemic medication and dementia subclass in type 2 diabetes mellitus using the Korean National Health Insurance System. Methods: This study included 701,193 individuals with diabetes prescribed dual oral therapy between 2009 and 2012 from the Korean National Health Insurance Service Database, which were tracked until 2017. All-cause, Alz
APA, Harvard, Vancouver, ISO, and other styles
39

Phillips, Susan A., Theodore P. Ciaraldi, Deborah K. Oh, Michelle K. Savu, and Robert R. Henry. "Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue." American Journal of Physiology-Endocrinology and Metabolism 295, no. 4 (2008): E842—E850. http://dx.doi.org/10.1152/ajpendo.90359.2008.

Full text
Abstract:
The subcutaneous (S) and visceral (V) adipose tissue (AT) depots are increasingly recognized as distinct. To test the hypothesis that depot differences exist for adiponectin, fresh and cultured human VAT and SAT from obese type 2 diabetic (T2D) and obese nondiabetic (ND) subjects was examined to determine whether differences in adiponectin content and secretion occurred as a function of depot studied, diabetic status, and response to thiazolidinedione treatment. VAT and SAT were obtained by biopsy and AT explants cultured in defined media for 7 days. Protein expression was assessed by Western
APA, Harvard, Vancouver, ISO, and other styles
40

Moon, Kyoung-Sik, Jung-Ho Noh, Yong-Bum Kim, et al. "Subacute toxicity study of CKD-501, a novel thiazolidinedione, after 4-week repeated oral administration in mice." Toxicology Letters 221 (August 2013): S255. http://dx.doi.org/10.1016/j.toxlet.2013.05.637.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Cabré, A., I. Lázaro, J. Girona, et al. "Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients." Atherosclerosis 195, no. 1 (2007): e150-e158. http://dx.doi.org/10.1016/j.atherosclerosis.2007.04.045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Arima, Shuji, Kentaro Kohagura, Kazuhisa Takeuchi, et al. "Biphasic Vasodilator Action of Troglitazone on the Renal Microcirculation." Journal of the American Society of Nephrology 13, no. 2 (2002): 342–49. http://dx.doi.org/10.1681/asn.v132342.

Full text
Abstract:
ABSTRACT. Recent studies have demonstrated that thiazolidinediones, novel antidiabetic compounds that improve the insulin sensitivity, lower BP and decrease urinary protein excretion. However, neither the target vasculature nor the underlying mechanism for their actions is well understood. In this study, the action of troglitazone (Tro), a thiazolidinedione compound, on the glomerular afferent (Af-Arts) and efferent (Ef-Arts) arterioles, crucial vascular segments to the control of glomerular hemodynamics, were directly examined. Rabbit Af-Arts or Ef-Arts were microdissected from the superficia
APA, Harvard, Vancouver, ISO, and other styles
43

Froes, Thamires Quadros, Rafael VC Guido, Kamel Metwally, and Marcelo Santos Castilho. "A novel scaffold to fight Pseudomonas aeruginosa pyocyanin production: early steps to novel antivirulence drugs." Future Medicinal Chemistry 12, no. 16 (2020): 1489–503. http://dx.doi.org/10.4155/fmc-2019-0351.

Full text
Abstract:
Aim: Although bacterial resistance is a growing concern worldwide, the development of antibacterial drugs has been steadily decreasing. One alternative to fight this issue relies on reducing the bacteria virulence without killing it. PhzS plays a pivotal role in pyocyanin production in Pseudomonas aeruginosa. Results: A total of 31 thiazolidinedione derivatives were evaluated as putative PhzS inhibitors, using thermo shift assays. Compounds that significantly shifted PhzS's Tm had their mode of inhibition (cofactor competitor) and affinity calculated by thermo shift assays as well. The most pr
APA, Harvard, Vancouver, ISO, and other styles
44

Lee, Sang Ah, Young Ree Kim, Eun Jin Yang, et al. "CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus." Journal of Clinical Endocrinology & Metabolism 98, no. 6 (2013): 2553–61. http://dx.doi.org/10.1210/jc.2012-4288.

Full text
Abstract:
Context: Dipeptidyl peptidase 4 (CD26/DPP4) is expressed on blood T cells and also circulates in a soluble form (sCD26/DPP4). Objective: We aimed to evaluate blood T cell and circulating CD26/DPP4 and its association with metabolic parameters in patients with type 2 diabetes mellitus (T2DM). Designs: We measured CD26/DPP4 expression (percentage of CD26+ cells using flow cytometry) on CD4+ and CD8+ T cells, serum CD26/DPP4 level and activity, and various metabolic parameters in T2DM patients not on DPP4 inhibitor therapy (n = 148). Nondiabetic subjects (n = 50) were included as a control group.
APA, Harvard, Vancouver, ISO, and other styles
45

Lgaz, Hassane, Sourav Kr Saha, Han-seung Lee, et al. "Corrosion Inhibition Properties of Thiazolidinedione Derivatives for Copper in 3.5 wt.% NaCl Medium." Metals 11, no. 11 (2021): 1861. http://dx.doi.org/10.3390/met11111861.

Full text
Abstract:
Copper is the third-most-produced metal globally due to its exceptional mechanical and thermal properties, among others. However, it suffers serious dissolution issues when exposed to corrosive mediums. Herein, two thiazolidinedione derivatives, namely, (Z)-5-(4-methylbenzylidene)thiazolidine-2,4-dione (MTZD) and (Z)-3-allyl-5-(4-methylbenzylidene)thiazolidine-2,4-dione (ATZD), were synthesized and applied for corrosion protection of copper in 3.5 wt.% NaCl medium. The corrosion inhibition performance of tested compounds was evaluated at different experimental conditions using electrochemical
APA, Harvard, Vancouver, ISO, and other styles
46

Sameeh, Manal Y., Manal M. Khowdiary, Hisham S. Nassar, et al. "Thiazolidinedione Derivatives: In Silico, In Vitro, In Vivo, Antioxidant and Anti-Diabetic Evaluation." Molecules 27, no. 3 (2022): 830. http://dx.doi.org/10.3390/molecules27030830.

Full text
Abstract:
This work aimed to synthesize a new antihyperglycemic thiazolidinedione based on the spectral data. The DFT\B3LYP\6-311G** level of theory was used to investigate the frontier molecular orbitals (FMOs), chemical reactivity and map the molecular electrostatic potentials (MEPs) to explain how the synthesized compounds interacted with the receptor. The molecular docking simulations into the active sites of PPAR-γ and α-amylase were performed. The in vitro potency of these compounds via α-amylase and radical scavenging were evaluated. The data revealed that compounds (4–6) have higher potency than
APA, Harvard, Vancouver, ISO, and other styles
47

Somayajulu, D. L. N., A. V. L. N. S. H. Hariharan, and Y. Subhash. "Solvent free synthesis of active 5-benzylidine-1, 3-thiazolidine-2,4-dione derivatives." Research Journal of Chemistry and Environment 25, no. 12 (2021): 68–71. http://dx.doi.org/10.25303/2512rjce6871.

Full text
Abstract:
Present communication describes the attempts made to improve the yields of thiazolidinedione group of derivatives keeping in view of their anti-cancer activity. 5-benzylidine-1,3-thiazolidine-2,4-dione derivatives were the active substrates belonging to α-glucosidase inhibitor classification. These were prepared by the reaction of 4-((Z)-(2,4-dioxothiazolidin-5-ylidene) methyl) benzaldehyde with aromatic/hetero aromatic ketones in the presence of potassium hydroxide and ethanol as solvent. Synthesis of 5-benzylidine-1, 3-thiazolidine-2,4-dione derivatives has been optimized under solvent free
APA, Harvard, Vancouver, ISO, and other styles
48

Haigh, David, Helen C. Birrell, Barrie C. C. Cantello, et al. "Non-thiazolidinedione antihyperglycaemic agents. Part 4: Synthesis of (±)-, (R)-(+)- and (S)-(−)-enantiomers of 2-oxy-3-arylpropanoic acids." Tetrahedron: Asymmetry 10, no. 7 (1999): 1335–51. http://dx.doi.org/10.1016/s0957-4166(99)00104-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Voskoboinikova, Halyna L., Yevhenii P. Bohuslavskyi, Victoria V. Dovzhuk, Liudmyla V. Konovalova, and Natela Sh Dovzhuk. "ASPECTS OF THE USE OF ANTIDIABETIC DRUGS IN PHARMACEUTICAL PRACTICE ON THE BASIS OF RATIONAL PHARMACOTHERAPY." Клінічна та профілактична медицина, no. 3 (May 8, 2024): 13–20. http://dx.doi.org/10.31612/2616-4868.3.2024.02.

Full text
Abstract:
The aim of the article. To study of the incidence of diabetes mellitus in Ukraine and to determine the prospects for the use and pharmaceutical development of antidiabetic drugs. Materials and methods. Data from the State Registers of Medicinal Products of Ukraine, of Wholesale and Retail Prices for Medicinal Products declared in Ukraine under an international non-proprietary or generic name (01.01.2024). Were used: systematic and comparative analysis, processing and synthesis, and generalization to determine the forecasted prospects. Results. In Ukraine the number of diabetes patients increas
APA, Harvard, Vancouver, ISO, and other styles
50

Lelyukh, Maryan, Myroslava Kalytovska, Marta Zastryzhna, Arkadii Savchenko, Ihor Chaban, and Stefan Harkov. "Synthesis and antitumor activity of 1,3,4-oxadiazole substituted 2-(5-ylidene-2,4-dioxothiazolidin-3-yl)-acetamides." Pharmacia 70, no. (4) (2023): 1093–100. https://doi.org/10.3897/pharmacia.70.e102449.

Full text
Abstract:
A series of novel 1,3,4-oxadiazole substituted 2-(5-aryl/heterylidene-2,4-dioxothiazolidine-3-ylidene)-acetamides and their 5-unsubstituted analogues have been synthesized following <i>N</i>-alkylation reaction of 2-chloro-<i>N</i>-(5-aryl-[1,3,4]oxadiazol-2-yl)-acetamides with thiazolidinedione and potassium salts of its arylidene derivatives. The structures of target compounds were confirmed by using 1H NMR spectroscopy and elemental analysis. Evaluation of anticancer activity <i>in vitro</i> for the synthesized compounds was performed in accordance with the National Cancer Institute protoco
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!